In conclusion, our study demonstrates the power of an integrated approach that combines computational and experimental methodologies. This hybrid strategy maximizes the efficiency of the drug discovery process and paves the way for the rapid development of novel therapeutic compounds. Future work will focus on further optimization of these active compounds and validation of their efficacy in relevant biological models, with the ultimate goal of contributing meaningful advances to the field of medicinal chemistry and drug development.